Astrazeneca Plc Adr Stock Alpha and Beta Analysis
AZN Stock | USD 71.20 0.35 0.49% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AstraZeneca PLC ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in AstraZeneca PLC over a specified time horizon. Remember, high AstraZeneca PLC's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AstraZeneca PLC's market risk premium analysis include:
Beta 0.65 | Alpha 0.0603 | Risk 1.26 | Sharpe Ratio 0.1 | Expected Return 0.13 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
AstraZeneca |
AstraZeneca PLC Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AstraZeneca PLC market risk premium is the additional return an investor will receive from holding AstraZeneca PLC long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AstraZeneca PLC. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AstraZeneca PLC's performance over market.α | 0.06 | β | 0.65 |
AstraZeneca PLC expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AstraZeneca PLC's Buy-and-hold return. Our buy-and-hold chart shows how AstraZeneca PLC performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.AstraZeneca PLC Market Price Analysis
Market price analysis indicators help investors to evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By understating and applying AstraZeneca PLC stock market price indicators, traders can identify AstraZeneca PLC position entry and exit signals to maximize returns.
AstraZeneca PLC Return and Market Media
The median price of AstraZeneca PLC for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 is 66.12 with a coefficient of variation of 3.29. The daily time series for the period is distributed with a sample standard deviation of 2.17, arithmetic mean of 66.03, and mean deviation of 1.56. The Stock received substential amount of media coverage during this period. Price Growth (%) |
Timeline |
AstraZeneca PLC dividend paid on 25th of March 2024 | 03/25/2024 |
1 | Biden celebrates drugmakers capping inhaler costs at 35 per month | 04/03/2024 |
2 | AstraZenecaDaiichis Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor | 04/08/2024 |
3 | Novo NordiskEli Lillys Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says | 04/12/2024 |
4 | AstraZeneca Imfinzi long-term survival buoyed by new data | 04/16/2024 |
5 | BenevolentAI Publication of the Revised Agenda for the 2024 AGM | 04/17/2024 |
6 | World Metastatic Prostate Cancer Drug Landscape Research Report 2024 Comprehensive Insights about 90 Companies and 110 Pipeline Drugs | 04/18/2024 |
7 | Roche wins FDA OK for targeted drug in early lung cancer | 04/19/2024 |
8 | Insights Into Astrazeneca Q1 Wall Street Projections for Key Metrics | 04/22/2024 |
About AstraZeneca PLC Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AstraZeneca or other stocks. Alpha measures the amount that position in AstraZeneca PLC ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0232 | 0.0206 | 0.0213 | 0.0285 | Price To Sales Ratio | 4.44 | 4.77 | 4.59 | 2.62 |
AstraZeneca PLC Upcoming Company Events
As portrayed in its financial statements, the presentation of AstraZeneca PLC's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AstraZeneca PLC's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AstraZeneca PLC's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AstraZeneca PLC. Please utilize our Beneish M Score to check the likelihood of AstraZeneca PLC's management manipulating its earnings.
8th of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
8th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with AstraZeneca PLC
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out AstraZeneca PLC Backtesting, AstraZeneca PLC Valuation, AstraZeneca PLC Correlation, AstraZeneca PLC Hype Analysis, AstraZeneca PLC Volatility, AstraZeneca PLC History and analyze AstraZeneca PLC Performance. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.